MyAverix Finance MyAverix Finance

HM · Other

TAKEDA PHARMA (TKD)

Other

TAKEDA PHARMA (TKD) is listed on HM in the Other sector. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for TKD

P/E ratio
18.00

TAKEDA PHARMA (TKD) — FAQ

What is TKD's P/E ratio?

The price-to-earnings (P/E) ratio for TAKEDA PHARMA (TKD) is 18.00 (data as of 2026-03-22).

Does TAKEDA PHARMA pay a dividend?

Dividend yield is not available in the current snapshot for TAKEDA PHARMA (TKD). Check the MyAverix Finance app for the latest dividend data.

What sector is TAKEDA PHARMA in?

TAKEDA PHARMA (TKD) is classified in the Other sector.

What exchange is TKD listed on?

TKD is listed on HM.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

Apple Inc (APC) Microsoft Corporation (MSF)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play